Finasteride: A 5 Alpha-Reductase Inhibitor

    January 1993 in “ PubMed ”
    James F. Steiner
    Studysummary This review discusses the pharmacology and clinical use of finasteride for benign prostatic hyperplasia and reports its effectiveness in reducing prostate size and symptoms, though success varies among patients.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on pubmed.ncbi.nlm.nih.gov →
    Discuss this study in the Community →

    Related research 5

    1. Dihydrotestosterone And The Role Of 5α-Reductase Inhibitors In Benign Prostatic Hyperplasia Der Urologe · 2002
    2. A Risk-Benefit Assessment of Treatment with Finasteride in Benign Prostatic Hyperplasia Drug safety · 1998
    3. Evaluation of Men on Finasteride PubMed · 1996
    4. 5-Alpha-Reductase Inhibitors/Finasteride PubMed · 1996
    5. Effect of Finasteride, a 5 Alpha-Reductase Inhibitor, on Serum Gonadotropins in Normal Men The Journal of Clinical Endocrinology and Metabolism · 1992